Sibrotuzumab: Difference between revisions

Jump to navigation Jump to search
m (Protected "Sibrotuzumab": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
 
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +))
 
Line 26: Line 26:
}}
}}
{{SI}}
{{SI}}
{{EH}}
 


==Overview==
==Overview==
Line 32: Line 32:


{{humanizedmonoclonals}}
{{humanizedmonoclonals}}
{{SIB}}
 
[[Category:Monoclonal antibodies]]
[[Category:Monoclonal antibodies]]
[[Category:Cancer treatments]]
[[Category:Cancer treatments]]
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Latest revision as of 16:02, 20 August 2012

Template:Drugbox-mab

WikiDoc Resources for Sibrotuzumab

Articles

Most recent articles on Sibrotuzumab

Most cited articles on Sibrotuzumab

Review articles on Sibrotuzumab

Articles on Sibrotuzumab in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Sibrotuzumab

Images of Sibrotuzumab

Photos of Sibrotuzumab

Podcasts & MP3s on Sibrotuzumab

Videos on Sibrotuzumab

Evidence Based Medicine

Cochrane Collaboration on Sibrotuzumab

Bandolier on Sibrotuzumab

TRIP on Sibrotuzumab

Clinical Trials

Ongoing Trials on Sibrotuzumab at Clinical Trials.gov

Trial results on Sibrotuzumab

Clinical Trials on Sibrotuzumab at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Sibrotuzumab

NICE Guidance on Sibrotuzumab

NHS PRODIGY Guidance

FDA on Sibrotuzumab

CDC on Sibrotuzumab

Books

Books on Sibrotuzumab

News

Sibrotuzumab in the news

Be alerted to news on Sibrotuzumab

News trends on Sibrotuzumab

Commentary

Blogs on Sibrotuzumab

Definitions

Definitions of Sibrotuzumab

Patient Resources / Community

Patient resources on Sibrotuzumab

Discussion groups on Sibrotuzumab

Patient Handouts on Sibrotuzumab

Directions to Hospitals Treating Sibrotuzumab

Risk calculators and risk factors for Sibrotuzumab

Healthcare Provider Resources

Symptoms of Sibrotuzumab

Causes & Risk Factors for Sibrotuzumab

Diagnostic studies for Sibrotuzumab

Treatment of Sibrotuzumab

Continuing Medical Education (CME)

CME Programs on Sibrotuzumab

International

Sibrotuzumab en Espanol

Sibrotuzumab en Francais

Business

Sibrotuzumab in the Marketplace

Patents on Sibrotuzumab

Experimental / Informatics

List of terms related to Sibrotuzumab


Overview

Sibrotuzumab is a humanized monoclonal antibody that is used to treat cancer.

Template:Humanizedmonoclonals

Template:WikiDoc Sources